FDA Cracks Down on Unapproved Eye Products

The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products, including eye products labeled to contain silver. These products are illegally marketed to treat conditions such as conjunctivitis, cataracts, and glaucoma. The FDA is concerned about the potential harm these unapproved drugs may cause, as they bypass the body's natural defenses and may lead to permanent discoloration of the skin and eye. Consumers are advised to consult their healthcare professionals if they are using any of the products mentioned in the warning letters. The FDA has requested the companies to respond within 15 days and failure to comply may result in legal action.